Alefacept

By Frampton J.E.   Wagstaff A.J.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 4, 2003-01 ,pp. : 277-286

Adis International

Access to resources Recommend Favorite

Thalidomide in Cutaneous Lupus Erythematosus

By Pelle M.T.   Werth V.P.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 6, 2003-01 ,pp. : 379-387

Adis International

Access to resources Recommend Favorite

An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis

By Weinberg J.M.  

Clinical Therapeutics, Vol. 25, Iss. 10, 2003-10 ,pp. : 2487-2505

Elsevier

Access to resources Recommend Favorite

Cutaneous Lupus Erythematosus: Diagnosis and Management

By Fabbri P.   Cardinali C.   Giomi B.   Caproni M.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 7, 2003-01 ,pp. : 449-465

Adis International

Access to resources Recommend Favorite

Effects of Alefacept on Health-Related Quality of Life in Patients with Psoriasis: Results from a Randomized, Placebo-Controlled Phase II Trial

By Ellis C.N.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 2, 2003-01 ,pp. : 131-139

Adis International

Access to resources Recommend Favorite